Dotinurad is a selective urate reabsorption inhibitor (SURI) utilized for the treatment of hyperuricemia and gout by inhibiting the urate transporter 1 (URAT1) in the kidneys to promote uric acid excretion.… Read more

































Dotinurad is a selective urate reabsorption inhibitor (SURI) utilized for the treatment of hyperuricemia and gout by inhibiting the urate transporter 1 (URAT1) in the kidneys to promote uric acid excretion. This category contains a comprehensive range of Dotinurad reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and relevant metabolites such as O-glucuronide and O-sulfate. These compounds are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and quality control. By utilizing these high-quality standards, analytical chemists can accurately identify and quantify potential degradants or synthetic by-products throughout the development lifecycle. Additionally, the inclusion of stable isotope labelled versions of Dotinurad supports precise mass spectrometry-based assays, ensuring reliable pharmacokinetic analysis and consistency in regulatory compliance testing. Each component is provided to facilitate accurate and reproducible analytical results within the pharmaceutical research and development environment.